Mateus, L.C.  |  Persona

publicaciones seleccionadas

• documento

  • A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells
  • A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells
  • Mesenchymal stem cells derivatives as a novel and potential therapeutic approach to treat diabetic foot ulcers